Consolidated Statements of Changes in Mezzanine Equity and Stockholders’ Equity - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			106,308,767
Beginning balance at Dec. 31, 2021	$ 309,852		$ 106	$ 682,084	$ (372,164)	$ (174)
Increase (Decrease) in Stockholders' Equity
Common stock dividends (in shares)			30,640
Issuance of common stock pursuant to exercise of stock options (in shares)			208,499
Stock issued during period, value, stock options exercised (in shares)	1,815		$ 0	1,815
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			684,357
Issuance of common stock pursuant to settlement of restricted stock units			$ 1	(1)
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (in shares)			(206,572)
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(2,595)			(2,595)
Stock-based compensation	17,922			17,922
Other comprehensive loss	(565)					(565)
Net loss	(90,806)				(90,806)
Ending balance (in shares) at Mar. 31, 2022			107,025,691
Ending balance at Mar. 31, 2022	235,623		$ 107	699,225	(462,970)	(739)
Beginning balance (in shares) at Dec. 31, 2021		40,000
Beginning balance at Dec. 31, 2021		$ 39,868
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net	$ 0	$ 11
Ending balance (in shares) at Mar. 31, 2022		40,000
Ending balance at Mar. 31, 2022		$ 39,879
Beginning balance (in shares) at Dec. 31, 2022	109,696,178		109,696,178
Beginning balance at Dec. 31, 2022	$ 63,953		$ 110	757,951	(693,307)	(801)
Increase (Decrease) in Stockholders' Equity
Common stock dividends (in shares)			30,640
Issuance of common stock pursuant to exercise of stock options (in shares)	18,037		18,037
Stock issued during period, value, stock options exercised (in shares)	$ 143		$ 0	143
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			1,155,826
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 1	(1)
Common stock surrendered for employees' tax liability upon settlement of restricted stock units (in shares)			(373,797)
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(3,162)		$ 1	(3,161)
Stock-based compensation	20,162			20,162
Other comprehensive loss	366					366
Net loss	$ (60,798)				(60,798)
Ending balance (in shares) at Mar. 31, 2023	110,526,884		110,526,884
Ending balance at Mar. 31, 2023	$ 20,664		$ 110	$ 775,094	$ (754,105)	$ (435)
Beginning balance (in shares) at Dec. 31, 2022	40,000	40,000
Beginning balance at Dec. 31, 2022	$ 39,914	$ 39,914
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		$ 11
Ending balance (in shares) at Mar. 31, 2023	40,000	40,000
Ending balance at Mar. 31, 2023	$ 39,925	$ 39,925